Published 7 days ago • loading... • Updated 6 days ago

APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit

Purchasers of Applied Therapeutics, Inc. Securities from January 3, 2024, to December 2, 2024, must act by February 18, 2025, to lead a class-action lawsuit, as highlighted by the Rosen Law Firm.
A class action lawsuit has been filed alleging that Applied Therapeutics concealed important clinical trial details, misleading investors regarding protocol adherence and the risk of FDA rejection.
The Rosen Law Firm states that affected investors may obtain compensation without upfront costs through a contingency fee arrangement.
The lawsuit contends that improper adherence to trial protocols posed significant risks of FDA rejection, causing investor damages when the truth emerged.

Insights by Ground AI

Does this summary seem wrong?

19 Articles

All

Left

Center

Right

The Conway Daily Sun

+17 Reposted by 17 other sources

APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Feb. 16, 2025 /PRNewswire/ -

7 days ago

Read Full Article

TownNews.com Content Exchange

INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Feb. 17, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, inclusive (the "Class…

6 days ago·Georgia, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year